Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
NCT06857240
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Dermatomyositis
Interventions
DRUG:
Ruxolitinib Topical Cream
Sponsor
The Cleveland Clinic